[ad_1]
LONDON (Reuters) – GlaxoSmithKline has quit the race to buy Pfizer’s consumer healthcare business, endangering an auction the U.S. drugmaker hoped would bring in as much as 14.2 billion pounds.
[ad_2]
Source link
GSK pulls out of £14.2 billion race for Pfizer consumer assets
